Articles On Immutep (ASX:IMM)

  Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt, Chief Scientific Officer Professor Frédéric Triebel, Chief Medical Officer Dr Florian Vogl, and Senior Vice President Strategic Development Christian Mueller present on Immu...

ASX to fall by 1pc when the market opens Amazon reaches $2 trillion market cap for the first time Aussie property market to remain strong in 2024   The ASX 200 is poised to fall sharply when the market opens on Thursday despite rallies in...

BrainChip Holdings Ltd (ASX: BRN) shares have had a turbulent first half of the year. Despite showing a 16% gain this year to date, nearly all of this occurred in the first two months of the year. After reaching a 52-week high of 54 cent...

Every investor has a different risk appetite. Some investors play it safe and buy low risk, defensive ASX stocks. Others are willing to risk a little for stronger potential returns. And a handful will seek the huge potential returns on offe...

Goldman Sachs is one of the most highly respected investment banks out there. Its analysts scour the globe for investment opportunities and then recommend them to investors. While the broker has buy ratings on a number of ASX shares, it has...

The ASX200 closed up 0.4% – thanks to a very small rise in Australia’s latest Gross Domestic Product data. Quarterly GDP rose just 0.1%, which is the slowest pace of GDP growth in one-and-a-half-years.  As far as the sectors went toda...

Aussie shares rise in arvo trade Resources sectors weigh, Real Estate adds 2pc GDP lowest in 40 years ex. COVID   The local bourse has come home with a sail wet on Wednesday with the ordinariness of our economy bringing market joy as it d...

The S&P/ASX 200 Index (ASX: XJO) is back on form on Wednesday and pushing higher. In afternoon trade, the benchmark index is up 0.4% to 7,768.7 points. Four ASX shares that have failed to follow the market higher today are listed below...

The Xero Ltd (ASX: XRO) share price is paused from trade on Wednesday morning. Why is the Xero share price paused? The company's shares are paused at present after Xero announced a major convertible notes offering. According to the release,...

Immutep (ASX:IMM) has launched a fully underwritten equity raising of approximately $100 million and a Phase 3 clinical trial collaboration with MSD.

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

ASX starts June positively, extending May gains  Property prices in Australia rose by 0.8% in May, with Sydney remaining the most expensive city Lovisa plunges by -10% as John Cheston takes over as CEO   The ASX has started the month of...

03 Jun 2024 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM), INOVIQ (ASX:IIQ) and Eastern Metals (ASX:EMS).

Immutep has launched a capital raise aiming to boost its war chest by $100 million to progress late-stage drug trials for lung cancer sufferers. The biotechnical company said apart from funding for its Phase 3 TATACTI004 trial encompassi...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

The All Ordinaries Index (ASX: XAO) is up a solid 0.5% on Monday, with one ASX All Ords share doing plenty of the heavy lifting. Shares in the sports betting company closed Friday at 45.5 cents. In morning trade today, they rocketed to 5...

If you have a higher than average risk tolerance, then it could be worth checking out the ASX penny stock listed below. Just over three years ago, this company was far from a penny stock with a share price over $15.00. But a lot has happene...

If you're looking for some big returns to supercharge your portfolio, then read on. That's because analysts at Bell Potter have just put buy ratings on three ASX stocks and tipped them to rise between 30% and 90%. Here's what the broker is...

Immutep shares promising early results from Phase 2 trial on soft tissue sarcoma (STS) This trial is the first of its kind, and evaluates IMM’s lead drug, efti STS is a rare cancer with limited treatment options   The clinical stage immun...

02 May 2024 - A snapshot of the stocks on the move, featuring Krakatoa Resources (ASX:KTA), Immutep (ASX:IMM) and ABx Group (ASX:ABX).

  To register for Friday's webinar click here. Krakatoa Resources (ASX:KTA) has announced that new niobium-REE gravity target has been identified at Mt Clere. The assays show an extensive 40 km long target catchment area potentially prospec...

Immutep (ASX:IMM) has announced initial encouraging data from EFTISARC-NEO, a Phase 2 investigator-initiated trial of eftilagimod alpha in combination with radiotherapy, a standard-of-care treatment, plus MSD's KEYTRUDA (pembrolizum...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

The S&P/ASX 200 Index (ASX: XJO) is on form again on Tuesday and pushing higher. At the time of writing, the benchmark index is up 0.2% to 7,651.4 points. Four ASX shares that have failed to follow the market higher today are listed b...

Pointsbet Holdings Ltd (ASX: PBH) shares are having a very tough session on Tuesday. In morning trade, the sports betting company's shares crashed as much as 45% to 45.5 cents. The company's shares have recovered a touch since then but rema...

A week or so ago, my young bloke's school invited parents to join the kids on a trip to the local cemetery, to take part in an ANZAC commemoration the school calls Honour Our Fallen. The kids were asked to talk about a family member who was...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

It was a mildly disappointing Wednesday for ASX investors today, with the S&P/ASX 200 Index (ASX: XJO) recording a slight loss. After spending most of the day in green territ...

The S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. In afternoon trade, the benchmark index is up 0.2% to 7,698.4 points. Four ASX shares that are rising more than most today are listed below. Here's why they are rac...

24 Apr 2024 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM; NASDAQ:IMMP), Western Mines Group (ASX:WMG) and Industrial Minerals (ASX:IND).

  Immutep (ASX:IMM; NASDAQ:IMMP) has announced preliminary topline results from Cohort B of the TACTI-003 Phase IIb trial. The trial evaluates efti in combination with MSD’s anti-PD-1 therapy KEYTRUDA® as first-line treatment for recurrent/...

  ASX to extend gains on Wednesday after Wall Street bounced back Tesla surged by 11pc after releasing quarterly results And where will the S&P 500 index be at year end?   Aussie shares are set to extend their good run on Wednesday a...

  The ASX close higher as unemployment rate came in lower than expected Miners rally, led by BHP as the giant released its Q3 report Nimy Resources up 50pc after reporting promising intercepts   The ASX added 0.5% on Thursday as the unemp...

  Nimy Resources (ASX:NIM) advises that drilling at Block 3 within its Mons project in WA has returned intersections of elevated copper, gold, silver mineralisation in massive sulphides plus high-grade gallium and rare earth oxide mineralis...

Immutep Limited (ASX:IMM) has entered into an agreement with the Centre for Human Drug Research (CHDR) in the Netherlands to perform a first-in-human clinical study of IMP761.

The ASX200 slipped into the red – but only by 0.09 of a per cent at close – with Utilities sporting a healthier disposition, up 2.84 per cent, as energy and healthcare slumped around half a per cent. In the green FRE  Australian he...

The ASX200 is up around a quarter of a per cent – beating futures predictions by about half a per cent. Utilities is up around 1.9 per cent – whilst energy and materials are falling off the pace. New Zealand’s inflation data has hit i...

18 Apr 2024 - A snapshot of the stocks on the move, featuring Nimy Resources, New Age Exploration and Immutep.

  Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer. Manny Anton: Hello. I'm Manny Ant...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

  Marc Voigt, Executive Director & CEO, Immutep (ASX:IMM) is a clinical-stage biotechnology company at the forefront of developing novel LAG-3 immunotherapy for cancer and autoimmune diseases.

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

At the $240 million Perennial Better Future Trust, healthcare stocks are a critical component of our ESG-focused portfolio. These stocks, many of which have global reach, have the potential to generate attractive returns while shaping a bet...

ASX health stocks rise in past five days and outpace broader markets Blue chip ResMed slips as US FDA approves weight loss drug Clinical stage immuno-oncology small cap Immutep gains 160%  Morgans healthcare and life sciences expert Iain...

  To register for Friday's webinar click here. Sunstone Metals (ASX:STM) announced the initial Exploration Target shows Limon is on track to be a substantial gold-silver deposit. In response, Sunstone Managing Director Malcolm Norris commen...

09 Nov 2023 - A snapshot of the stocks on the move, featuring Sunstone Metals (ASX:STM), Immutep (ASX:IMM, NASDAQ:IMMP), European Metals Holdings (ASX:EMH & AIM:EMH) and QX Resourc…

ASX to rise despite a muted session on Wall Street Oil plunged another 2pc overnight, possibly signalling a recession S&P released the 10 most shorted stocks on the ASX   Aussie shares are poised to open higher on Thursday as Wall Str...

Immutep (ASX:IMM) has announced that the open-label safety lead-in of its integrated AIPAC-003 Phase 2/3 trial evaluating 90mg of eftilagimod alpha in combination with paclitaxel has been completed with no safety or tolerability iss...

The ASX experienced a subdued Monday session, with its benchmark index nearing 7000 points for the first time in over two weeks, anticipating the Reserve Bank's impending cash rate decision. Australia's central bank is anticipated to raise...